vinpocetine has been researched along with ADDH in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golani, LK; Luhach, K; Sharma, B; Sharma, N; Singh, B | 1 |
| Abreu-Villaça, Y; Ferreira-Rosa, K; Filgueiras, CC; Kubrusly, RC; Manhães, AC; Nunes, F; Pereira, Mdos S | 1 |
2 other study(ies) available for vinpocetine and ADDH
| Article | Year |
|---|---|
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Ethanol; Female; Humans; Interleukin-10; Interleukin-6; Oxidative Stress; Phosphoric Diester Hydrolases; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2022 |
Acute administration of vinpocetine, a phosphodiesterase type 1 inhibitor, ameliorates hyperactivity in a mice model of fetal alcohol spectrum disorder.
Topics: Alcohol Drinking; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Cyclic AMP; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Humans; Male; Mice; Motor Activity; Phosphodiesterase Inhibitors; Pregnancy; Pregnancy Complications; Single-Blind Method; Survival Rate; Vinca Alkaloids; Weight Gain | 2011 |